Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ12111213-0,16
KB103210350,39
PKN85,3385,351,08
Msft497,5498,20,06
Nokia4,4044,408-0,65
IBM292,9293,50,21
Mercedes-Benz Group AG49,8649,87-0,07
PFE25,2525,260,08
08.07.2025 11:23:01
Indexy online
AD Index online
select
AD Index online
 

  • 07.07.2025
Pharma-Bio Serv (US Other OTC (Pink Sheets))
Závěr k 7.7.2025 Změna (%) Změna (USD) Objem obchodů (ks)
0,60 0,00 0,00 100
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 08.07.2025
Popis společnosti
Obecné informace
Název společnostiPharma-Bio Serv Inc
TickerPBSV
Kmenové akcie:Ordinary Shares
RICPBSV.PK
ISIN-
Prioritní akciePreference Shares
Poslední známé roční výsledky31.10.2024
Poslední známé čtvrtletní výsledky30.04.2025
Počet zaměstnanců k 31.10.2024 75
Akcie v oběhu k 10.06.2025 22 927 942
MěnaUSD
Kontaktní informace
UlicePharma-Bio Serv Building,#6 Road 696
MěstoDORADO
PSČ00646
ZeměPuerto Rico
Kontatní osobaScott Gordon
Funkce kontaktní osobyInvestor Relations
Telefon17 872 782 709
Kontatní telefon16 317 034 900

Business Summary: Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The Company provides a range of compliance-related consulting services. The Company provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The Company's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.
Financial Summary: BRIEF: For the three months ended 31 January 2025, Pharma-Bio Serv Inc revenues increased 4% to $2.5M. Net income totaled $9K vs. loss of $271K. Revenues reflect Europe consulting segment increase from $65K to $721K, Europe segment increase from $65K to $721K. Net Income reflects Selling/General/Admin. E decrease of 12% to $860K (expense).
Odvětvová klasifikace
TRBC2009Business Support - Services
TRBC2012Management Consulting Services
RBSS2004Commercial Services & Supplies
MGINDUSTRYBusiness Services
MGSECTORServices
NAICSOther Management Consulting Services
NAICSComputer Systems Design Services
NAICSAdministrative Management and General Management Consulting Services
NAICS2007Other Management Consulting Services
NAICS2007Computer Systems Design Services
NAICS2007Admin & Gen Management Consulting Services
NAICS1997Other Management Consulting Services
NAICS1997Computer Systems Design Services
NAICS1997Administrative Management and General Management Consulting Services
SICManagement Consulting Services
SICBusiness Consulting, Nec
SICComputer Integrated System Design
SICManagement Consulting Services



  • Poslední aktualizace: 08.07.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, President, President of European OperationsVictor Sanchez5201.01.2015
Chief Financial Officer, Vice President - Finance and Administration, SecretaryPedro Lasanta6301.12.2014